In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Expansion of drug discovery collaboration for Ingenium and Elan
Elan sells Actiq rights to Cephalon
aaiPharma acquires pain products from Elan for $100 million
Beyond Genomics Forms Joint Venture with Elan
Elan and Ingenium announce major alliance
aaiPharma acquires pain products from Elan
Atrix and Elan agree research partnership